Marchex, Inc. - Class B Common Stock (MCHX)

Marchex reports Q3 2025 results, missing revenue but meeting profit targets. The stock rose on news of its strategic Archenia acquisition and a positive 2026 growth outlook.

Marchex (MCHX) Q3 2025 Earnings Call Transcript

Marchex posted mixed Q2 2025 results with revenue missing estimates but adjusted EBITDA and EPS improving. AI-driven growth and new partnerships signal future potential despite short-term challenges.

MCHX stock results show that Marchex missed on revenue for the fourth quarter of 2023.

MCHX stock results show that Marchex met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

MCHX stock results show that Marchex met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.